Reports for NATCO PHARMA (CANADA) INC
Company Name
NATCO PHARMA (CANADA) INC
Totals |
||
Shortage reports |
26 |
|
Actual shortage: | 10 (38%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 16 (62%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
1 (4%) |
|
Overdue reports |
5 (50%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NAT-ESCITALOPRAM | 20MG | TABLET | Actual shortage | 2024-02-02 | 2024-04-08 | 218258 |
NAT-ERLOTINIB | 25MG | TABLET | Actual shortage | 2020-12-03 | 2024-02-02 | 129536 |
NAT-ERLOTINIB | 100MG | TABLET | Actual shortage | 2020-12-03 | 2024-02-02 | 129550 |
NAT-ERLOTINIB | 150MG | TABLET | Actual shortage | 2020-12-03 | 2024-02-02 | 129553 |
NAT-EVEROLIMUS | 2.5MG | TABLET | Actual shortage | 2024-04-29 | 2024-04-30 | 226575 |
NAT-PREGABALIN | 225MG | CAPSULE | Actual shortage | 2023-05-17 | 2024-02-02 | 192650 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0